The cell-free protein expression industry faces significant challenges due to the high costs associated with protein expression systems. Developing these systems requires substantial R&D investments, making them more expensive than in vivo methods. Additionally, commercial-scale production remains costly, limiting wider adoption as expenses are often passed on to end-users. Simplifying system compositions could help reduce costs over time.
Market Opportunity - Emerging applications in precision medicine, drug discovery and synthetic biology
Cell-free protein expression is poised for significant growth in emerging applications such as precision medicine, drug discovery, and synthetic biology. These systems facilitate rapid, personalized production of therapeutics tailored to individual genetic profiles and enable the efficient synthesis of novel biologics, enhancing research capabilities and accelerating drug development processes.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients